Skip to main content
Ryoichi Honda on Muck Rack

Ryoichi Honda

As seen in: MDPI, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ryoichi

Contact Ryoichi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cancers | Free Full-Text | Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study

|
By Keiko Tanimura, Takayuki Takeda, Akihiro Yoshimura, Ryoichi Honda
| MDPI
3. Results 3.1. Characteristics of Patients In total, 133 patients were enrolled in this study and 7 patients were excluded due to data unavailability (Supplementary Figure S1). The median duration of follow-up for surviving participants was 16.3 months (95% confidence interval [CI]: 14.7–20.8 months). The baseline characteristics of the 126 patients at the time of durvalumab initiation are summarized in Table 1.
Open in Who Shared Issue with article?
See all 1 articles